#ESLA #ESLAW Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
www.stocktitan.net/news/ESLA/estrella-immun...
0
0
0
0
#ESLA #ESLAW Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
www.stocktitan.net/news/ESLA/estrella-immun...
#ESLA #ESLAW Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort
www.stocktitan.net/news/ESLA/estrella-immun...
#ESLA #ESLAW Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
www.stocktitan.net/news/ESLA/estrella-immun...